Metabolism and Target Organ Damage
All Journals
Search Log In
Home Articles Special Issues Volumes Webinars Videos
Metabolism and Target Organ Damage
Search Submit
Home Articles Special Issues Volumes Webinars Videos

fig1

From:  Mini liver organoid models emulating metabolic dysfunction-associated steatotic disease development: gradually emerging beneath the iceberg
Mini liver organoid models emulating metabolic dysfunction-associated steatotic disease development: gradually emerging beneath the iceberg

Figure 1. Hepatocyte organoids originated from Lgr5+ stem cells, PLC, human pluripotent stem cells, human induced pluripotent stem cells, and human chemically-derived hepatic progenitors for investigating MASLD progression. MASLD: Metabolic dysfunction-associated steatotic liver disease; NASH: non-alcoholic steatohepatitis; PSCs: pluripotent stem cells; ESCs: embryonic stem cells; hiPSC: human-induced pluripotent stem cells; PLC: primary liver cells; HUVECs: human umbilical vein endothelial cells.

Metabolism and Target Organ Damage
ISSN 2769-6375 (Online)
Navigation
Follow Us
Navigation

Committee on Publication Ethics

https://members.publicationethics.org/members/metabolism-and-target-organ-damage

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Committee on Publication Ethics

https://members.publicationethics.org/members/metabolism-and-target-organ-damage

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/
Discover Content
Follow OAE
Twitter
Facebook
LinkedIn
YouTube
BiLiBiLi
WeChat
© 2016-2025 OAE Publishing Inc., except certain content provided by third parties